Royal Bank Of Canada Haemonetics Corp Call Options Transaction History

Royal Bank Of Canada

  • $471 Billion
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

Nov 05, 2024
BUY
$71.24 - $85.35 $1.67 Million - $2 Million
23,400 New
23,400 $2 Million
Q1 2024

May 15, 2024
BUY
$71.24 - $85.35 $1.06 Million - $1.27 Million
14,900 Added 175.29%
23,400 $2 Million
Q4 2023

Feb 14, 2024
BUY
$80.59 - $92.61 $685,015 - $787,185
8,500 New
8,500 $726,000

Others Institutions Holding HAE

# of Institutions
333
Shares Held
54M
Call Options Held
689K
Put Options Held
345K
View Full List

About HAEMONETICS CORP

HAE Quotes by TradingView
  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.36B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email